Anti-tumour and anti-angiogenetic effects of zoledronic acid on human non-small-cell lung cancer cell line
✍ Scribed by M. Di Salvatore; A. Orlandi; C. Bagalà; M. Quirino; A. Cassano; A. Astone; C. Barone
- Book ID
- 108678032
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 633 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0960-7722
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The epidermal growth factor receptor (EGFR) tyrosine‐kinase inhibitor gefitinib (Iressa®, ZD1839) has shown promising activity preclinically and clinically. Because comparative investigations of drug‐resistant sublines with their parental cells are useful approaches to identifying the m
The effects of bombesin on three human small cell lung carcinoma cell (SCLC) lines (NCI-H69, NCI-H128, and NCI-H345) have been examined and compared to the effects of the peptide on the mouse fibroblast cell line Swiss 3T3, and the rat pituitary tumor cell line GH3W5. While all three SCLC lines expr